Market Overview:
The global diagnostic testing for STDs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of STDs, growing awareness about early diagnosis and treatment of STDs, and technological advancements in diagnostic testing for STDs. The global diagnostic testing for STDs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into syphilis testing, gonorrhea testing, chlamydiatesting herpes simplex virus (HSV)testing human immunodeficiency virus (HIV)testing human papilloma virus (HPV)testing and others. HSV Testing held a major share in 2017 owing to its high prevalence across all regions globally. HPV Testing is expected to grow at a highest CAGR during the forecast period due to rising awareness about HPV-related cancers such as cervical cancer among women worldwide ChlamydiaTesting held second largest share in 2017 due its high prevalence rates among young adults globally .On the basis application ,the global diagnostic testing for STD’smarketis divided into laboratory testsand point-of-care tests .
Product Definition:
Diagnostic Testing For STDs is the process of testing a person for the presence of sexually transmitted diseases. This testing can be done through various means, including blood tests, urine tests, and swab tests. The importance of Diagnostic Testing For STDs is that it allows for the early detection and treatment of any potential infections.
Syphilis Testing:
Syphilis Testing, it's usage and growth factor in Diagnostic Testing For STDs market is a study of the Syphilis testing industry. It includes syphilis test procedures, equipment used for these procedures along with their prices. The study also throws light on current market trends and provides an analysis of future opportunities in the global syphilis testing, it's usage & growth factors in diagnostic testing for stds market over the forecast period.
Gonorrhea Testing:
The gonorrhea testing is used in the diagnostic testing for sexually transmitted diseases. It is a procedure that involves detection of the antibodies formed by the immune system in response to gonococcal infection. The most commonly used method for detecting this disease is through urine test, however, blood tests are also performed on some occasions.
Urine Test: This test can detect both urethritis and cervicopsy as well as confirm if an individual has been infected with gonorrhea bacteria.
Application Insights:
Laboratory testing segment held the largest share of over 70.0% in 2017. This is due to the availability of advanced diagnostic techniques for various STDs, such as HIV and hepatitis that are detected only by laboratory tests. Furthermore, an increase in the number of government initiatives to control these diseases will boost market growth during the forecast period.
The point of care testing segment is expected to grow at a lucrative rate during the study period owing to its ability to detect infections with high specificity and sensitivity which has resulted in increased use across clinics and hospitals worldwide. Moreover, increasing awareness about this method among patients will further boost demand over next seven years.
STD treatment through medication has proven effective but it can be expensive both financially.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising prevalence of sexually transmitted diseases, increasing government initiatives and awareness campaigns regarding testing, and availability of advanced treatment options in this region. For instance, as per CDC statistics published in June 2018 issue of Morbidity & Mortality Weekly Report (MMWR), around 6 million people were diagnosed with chlamydia annually while Gonorrhea infection rate was around 120 thousand per year.
Growth Factors:
- Increasing incidence of sexually transmitted diseases (STDs)
- Growing awareness about the benefits of early diagnosis and treatment of STDs
- Rising demand for rapid and accurate diagnostic tests for STDs
- Technological advancements in diagnostic testing for STDs
- Growing number of private clinics and laboratories offering diagnostic testing services for STDs
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Testing For STDs Market Research Report
By Type
Syphilis Testing, Gonorrhea Testing, Chlamydia Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Others
By Application
Laboratory Testing, Point Of Care Testing
By Companies
Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin S.p.A, F.Hoffman La-Roche Ltd., Hologic, Inc., MedMira, Inc., Qiagen, Inc., Siemens Healthcare AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Testing For STDs Market Report Segments:
The global Diagnostic Testing For STDs market is segmented on the basis of:
Types
Syphilis Testing, Gonorrhea Testing, Chlamydia Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory Testing, Point Of Care Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Diasorin S.p.A
- F.Hoffman La-Roche Ltd.
- Hologic, Inc.
- MedMira, Inc.
- Qiagen, Inc.
- Siemens Healthcare AG
Highlights of The Diagnostic Testing For STDs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syphilis Testing
- Gonorrhea Testing
- Chlamydia Testing
- Herpes Simplex Virus Testing
- Human Immunodeficiency Virus Testing
- Human Papilloma Virus Testing
- Others
- By Application:
- Laboratory Testing
- Point Of Care Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Testing For STDs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one test that can diagnose all STDs. Different tests are needed to detect different types of infections. Some common STD tests include:nn-A blood test to check for signs of infection, such as antibodies against a particular virus or bacterian-A urine test to look for the presence of specific chemicals that may be associated with an STD infectionn-An examination of the inside walls of the vagina or anus (anoscopy) to see if there are any signs of an STD infection, such as lesions or discharge
Some of the major players in the diagnostic testing for stds market are Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin S.p.A, F.Hoffman La-Roche Ltd., Hologic, Inc., MedMira, Inc., Qiagen, Inc., Siemens Healthcare AG.
The diagnostic testing for stds market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diagnostic Testing For STDs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diagnostic Testing For STDs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diagnostic Testing For STDs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diagnostic Testing For STDs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diagnostic Testing For STDs Market Size & Forecast, 2018-2028
4.5.1 Diagnostic Testing For STDs Market Size and Y-o-Y Growth
4.5.2 Diagnostic Testing For STDs Market Absolute $ Opportunity
Chapter 5 Global Diagnostic Testing For STDs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diagnostic Testing For STDs Market Size Forecast by Type
5.2.1 Syphilis Testing
5.2.2 Gonorrhea Testing
5.2.3 Chlamydia Testing
5.2.4 Herpes Simplex Virus Testing
5.2.5 Human Immunodeficiency Virus Testing
5.2.6 Human Papilloma Virus Testing
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diagnostic Testing For STDs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diagnostic Testing For STDs Market Size Forecast by Applications
6.2.1 Laboratory Testing
6.2.2 Point Of Care Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diagnostic Testing For STDs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diagnostic Testing For STDs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diagnostic Testing For STDs Analysis and Forecast
9.1 Introduction
9.2 North America Diagnostic Testing For STDs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diagnostic Testing For STDs Market Size Forecast by Type
9.6.1 Syphilis Testing
9.6.2 Gonorrhea Testing
9.6.3 Chlamydia Testing
9.6.4 Herpes Simplex Virus Testing
9.6.5 Human Immunodeficiency Virus Testing
9.6.6 Human Papilloma Virus Testing
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diagnostic Testing For STDs Market Size Forecast by Applications
9.10.1 Laboratory Testing
9.10.2 Point Of Care Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diagnostic Testing For STDs Analysis and Forecast
10.1 Introduction
10.2 Europe Diagnostic Testing For STDs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diagnostic Testing For STDs Market Size Forecast by Type
10.6.1 Syphilis Testing
10.6.2 Gonorrhea Testing
10.6.3 Chlamydia Testing
10.6.4 Herpes Simplex Virus Testing
10.6.5 Human Immunodeficiency Virus Testing
10.6.6 Human Papilloma Virus Testing
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diagnostic Testing For STDs Market Size Forecast by Applications
10.10.1 Laboratory Testing
10.10.2 Point Of Care Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diagnostic Testing For STDs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diagnostic Testing For STDs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diagnostic Testing For STDs Market Size Forecast by Type
11.6.1 Syphilis Testing
11.6.2 Gonorrhea Testing
11.6.3 Chlamydia Testing
11.6.4 Herpes Simplex Virus Testing
11.6.5 Human Immunodeficiency Virus Testing
11.6.6 Human Papilloma Virus Testing
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diagnostic Testing For STDs Market Size Forecast by Applications
11.10.1 Laboratory Testing
11.10.2 Point Of Care Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diagnostic Testing For STDs Analysis and Forecast
12.1 Introduction
12.2 Latin America Diagnostic Testing For STDs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diagnostic Testing For STDs Market Size Forecast by Type
12.6.1 Syphilis Testing
12.6.2 Gonorrhea Testing
12.6.3 Chlamydia Testing
12.6.4 Herpes Simplex Virus Testing
12.6.5 Human Immunodeficiency Virus Testing
12.6.6 Human Papilloma Virus Testing
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diagnostic Testing For STDs Market Size Forecast by Applications
12.10.1 Laboratory Testing
12.10.2 Point Of Care Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diagnostic Testing For STDs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diagnostic Testing For STDs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diagnostic Testing For STDs Market Size Forecast by Type
13.6.1 Syphilis Testing
13.6.2 Gonorrhea Testing
13.6.3 Chlamydia Testing
13.6.4 Herpes Simplex Virus Testing
13.6.5 Human Immunodeficiency Virus Testing
13.6.6 Human Papilloma Virus Testing
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diagnostic Testing For STDs Market Size Forecast by Applications
13.10.1 Laboratory Testing
13.10.2 Point Of Care Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diagnostic Testing For STDs Market: Competitive Dashboard
14.2 Global Diagnostic Testing For STDs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories, Inc.
14.3.2 Bio-Rad Laboratories, Inc.
14.3.3 Danaher Corporation
14.3.4 Diasorin S.p.A
14.3.5 F.Hoffman La-Roche Ltd.
14.3.6 Hologic, Inc.
14.3.7 MedMira, Inc.
14.3.8 Qiagen, Inc.
14.3.9 Siemens Healthcare AG
